Effects of tofersen treatment in patients with SOD1-ALS in a “real-world” setting – a 12-month multicenter cohort study from the German early access program
2024 · EClinicalMedicine · 94 citations
https://doi.org/10.1016/j.eclinm.2024.102495
F
Franziska Bachhuber
Universität Ulm(DE)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
44
Papers
588
Citations
8
h-index
8
i10-index
Franziska Bachhuber is an academic researcher from Universität Ulm. The author has contributed to research in topics: Amyotrophic Lateral Sclerosis Research & Multiple Sclerosis Research Studies & Parkinson's Disease Mechanisms and Treatments. The author has an h-index of 8, co-authored 38 publications.
ORCID: 0000-0003-1031-9966Papers by this author
worksSerum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis
2023 · Journal of Neurology Neurosurgery & Psychiatry · 19 citations
https://doi.org/10.1136/jnnp-2023-332251
Primary lateral sclerosis: application and validation of the 2020 consensus diagnostic criteria in an expert opinion-based PLS cohort
2024 · Journal of Neurology Neurosurgery & Psychiatry · 6 citations
https://doi.org/10.1136/jnnp-2023-333023
Blood biomarkers for predicting disability worsening in progressive multiple sclerosis: a multinational, individual participant-level analysis
2025 · Journal of Neurology Neurosurgery & Psychiatry · 5 citations
https://doi.org/10.1136/jnnp-2025-335831
Comparative analysis of cerebrospinal fluid neurofilament medium, light and heavy chain in neurodegenerative diseases using an in-house assay for the detection of neurofilament medium chain
2025 · EBioMedicine · 1 citations
https://doi.org/10.1016/j.ebiom.2025.105930
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat